Fukunaga, Tsugumi
Anan, Go https://orcid.org/0000-0001-8325-2606
Hirose, Takuo
Miyake, Yuka
Hoshino, Kento
Endo, Akari
Tajima, Ryo
Ito, Hiroki
Nakayama, Shingo
Hashimoto, Hideaki
Ishiyama, Katsuya
Kimura, Tomoyoshi
Mori, Takefumi
Funding for this research was provided by:
Japan Society for the Promotion of Science (19K21596, 19H03677)
Article History
Received: 26 September 2021
Accepted: 24 February 2022
First Online: 11 March 2022
Declarations
:
: The Division of Integrative Renal Replacement Therapy (T.H. and T.M.) is financially supported by Chugai Pharmaceutical Co., Ltd., Terumo Corporation, and JMS Co., Ltd. All the other authors have no conflict of interest.
: The study was conducted in accordance with the principles of the latest version of the Declaration of Helsinki and was approved by the ethics committee of Tohoku Medical and Pharmaceutical University Hospital, Japan (Protocol 2016-2-008).
: Written informed consent was obtained from all the patients.